More on ALGS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+85.4% Growth)
- Ratings (6.3 Score)

Upcoming Events

- Earnings (6/2/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Aligos Therapeutics Inc. (NQ:ALGS)
Delayed: 6.98 +0.32 (4.80%)
Prev. Close $6.66  
Open$6.40 
52 Wk High$ 
52 Wk Low$ 
Day High$7.37 
Day Low$6.37 
P/E N/A  
EPS$ 
Volume87,212 


Mar 5, 2026 04:02 PM Aligos Therapeutics Inc. (ALGS) Misses Q4 EPS by 191c
Mar 5, 2026 08:28 AM Form S-8 Aligos Therapeutics,
Mar 5, 2026 08:09 AM Form 10-K Aligos Therapeutics, For: Dec 31
Mar 5, 2026 08:02 AM Form 8-K Aligos Therapeutics, For: Mar 05
Mar 5, 2026 08:00 AM Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
Feb 26, 2026 08:00 AM Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026
Feb 23, 2026 08:00 AM Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
Feb 19, 2026 05:54 PM Form 3 Aligos Therapeutics, For: Jan 29 Filed by: Aneja Nikhil
Feb 17, 2026 03:22 PM Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: Woodline Partners LP
Feb 11, 2026 04:32 PM Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: Sio Capital Management, LLC
View All Articles

Entities mentioned with ALGS

View All Entities